Tesamorelin 10MG

Tesamorelin is a synthetic peptide analog derived from human growth hormone-releasing hormone (GHRH). This product is intended for research and academic studies only, as part of pharmaceutical or scientific investigations concerning its potential effects on biological systems. Below is detailed information regarding its chemical properties, research applications, and context within the peptide science field.

Research Context

Tesamorelin was initially developed as a potential therapeutic agent for the treatment of HIV-associated lipodystrophy, characterized by significant fat redistribution and metabolic disturbances. In clinical studies, it demonstrated selective activation of growth hormone secretion, which can influence lipolysis and fat redistribution in animal models. Due to its specificity in targeting lipodystrophy mechanisms, tesamorelin remains a key compound in studies exploring metabolic and hormonal regulation.

Research Overview

Tesamorelin 10MG is provided in a highly purified form, suitable for biochemical, molecular biology, and pharmacological research. Its structure mimics natural GHRH, allowing for targeted receptor engagement to investigate downstream signaling pathways in vitro and in vivo. Researchers often employ tesamorelin to study the effects on lipid metabolism, muscle protein synthesis, and hormonal interactions in controlled experimental settings.

Key Research Focus Areas

• Metabolic and Lipid Regulation:
  Tesamorelin has been studied for its potential to modulate fat distribution, particularly in conditions such as lipodystrophy, by enhancing lipolysis while sparing muscle protein turnover.
• Growth Hormone Signaling:
  Research has examined the direct impact of tesamorelin on growth hormone (GH) secretion and its influence on insulin-like growth factor-1 (IGF-1) levels in various physiological and pathological states.
• In vitro and In vivo Studies:
  The peptide is frequently utilized in cell culture models to analyze receptor binding, second messenger activation, and gene expression changes associated with GHRH signaling pathways.
• Pharmacological Profiling:
  Tesamorelin serves as a probe to differentiate between GHRH and growth hormone secretagogues, aiding in the development of more selective therapeutic agents.

Important Compliance and Safety Note

This product is strictly intended for use in accredited academic and research institutions by qualified personnel. Due to the lack of human and veterinary safety data under clinical conditions, any experimental use must adhere to institutional guidelines, ethical protocols, and regulatory standards applicable to the research facility. Proper handling, storage, and disposal procedures should be followed to minimize risk.

For research use only. Not for human or animal consumption.